Search the Newsreel

Arrowstreet Capital Limited Partnership Trims Stake in Amneal Pharmaceuticals, Inc. $AMRX

Amneal Pharma A earnings beat by $0.07, revenue topped estimates

Amneal Pharma A (NASDAQ: AMRX) reported strong second-quarter results, surpassing analyst estimates with EPS of $0.300 and revenue of $796.2 million. The company also provided optimistic full-year 2026 guidance, expecting EPS between $0.960-$1.060 and revenue between $3.100B-$3.200B. AMRX stock has shown significant growth, increasing …

Is MaxLinear’s Panther AI Storage Push Reframing Its Data Center Ambitions (MXL)?

MaxLinear (MXL) is showcasing its Panther Storage Accelerator platform, designed to boost AI and storage efficiency through hardware-accelerated compression, encryption, and data movement. This initiative reinforces the company's pivot towards AI data center solutions, aiming to offset pressures in mature broadband markets. While Panther …

Q1 2026 Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP Earnings Call (English, Portuguese) Transcript

Companhia de Saneamento Basico do Estado de Sao Paulo (SABESP) reported strong financial results for Q1 2026, with adjusted net revenue increasing 11% year-on-year to $6 billion and adjusted EBITDA up 26% to $3.8 billion. The company highlighted increased CapEx, a robust liquidity position, …

Enterprise value to EBIT forward of Maui Land & Pineapple Company, Inc. – NYSE:MLP

The article focuses on the enterprise value to EBIT forward of Maui Land & Pineapple

Residents of Multiple Communities Sue Lineage Inc. Over June Warehouse Fire

Multiple communities are suing Lineage Inc. over a June warehouse fire in Boyle Heights, alleging negative impacts on their lives and health from smoke, ash, and chemicals. The lawsuit seeks unspecified compensatory and punitive damages, citing public nuisance, negligence, trespass, and premises liability. Plaintiffs …

Amneal (AMRX) Stock Looks Fairly Valued Following Raised 2026 Guidance

Lineage fire: East LA family camps near beach to escape stench from warehouse destroyed in fire in Boyle Heights

A mother of four from East Los Angeles has moved her family to camp near the beach to escape the unbearable stench of rotting food from the Lineage warehouse fire in Boyle Heights. Despite the company's efforts to provide relief and housing vouchers, her …

Vanguard Capital Management (MXL) discloses 4.48M-share, 5% holding in MaxLinear

Vanguard Capital Management has disclosed a 5% beneficial ownership stake in MaxLinear Inc, holding 4,480,681 shares of common stock. This filing, a Schedule 13G, indicates that Vanguard has sole voting power over 657,779 shares and sole dispositive power over all 4,480,681 shares. The ownership …

Amneal (AMRX) Stock Looks About Fair Value On Current Earnings

Lineage Cell Therapeutics (LCTX) to Post Earnings on Thursday

First Trust Advisors LP Acquires 116,873 Shares of Amneal Pharmaceuticals, Inc. $AMRX

Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp (NYSE:SBS) Downgraded to "Hold" Rating by Wall Street Zen

Wall Street Zen and Zacks Research have both downgraded Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp (NYSE:SBS) to a "Hold" rating, though the consensus among analysts remains a "Moderate Buy" with a $183 price target. The downgrades follow SABESP reporting …

AMRX Q2 Deep Dive: Diversified Product Mix and Biosimilars Strategy Shape Guidance

AMRX Q2 Deep Dive: Diversified Product Mix and Biosimilars Strategy Shape Guidance Pharmaceutical company Amneal Pharmaceuticals (NASDAQ:AMRX) reported Q2 CY2026 results topping the market's revenue expectations , with sales up 9.9% year on year to $796.2 million. The company's full-year revenue guidance of $3.15 …

Vanguard Portfolio Management (MXL) discloses 7.82% beneficial stake in MaxLinear

Vanguard Portfolio Management LLC has filed an amended Schedule 13G, disclosing a 7.82% beneficial ownership stake in MaxLinear Inc. This represents 7,008,350 shares of common stock as of June 30, 2026. Vanguard maintains sole voting power over 84,922 shares and sole dispositive power over …

Amneal Pharmaceuticals (AMRX) Stock Asks If Profit Momentum Can Endure

Amneal Pharmaceuticals (AMRX) reported a strong Q2 with increased revenue and adjusted EPS, leading to a raised full-year outlook. While the company is transitioning towards higher-margin biosimilars and injectables, investor concern centers on the sustainability of this profit momentum given increased capital expenditure and …

Price-Driven Insight from (MXL) for Rule-Based Strategy

This article provides a price-driven analysis of Maxlinear Inc (NYSE: MXL) for rule-based trading strategies. It highlights a weak near and mid-term sentiment potentially challenging a long-term positive outlook, with an exceptional risk-reward short setup. The analysis details institutional trading strategies including position trading, …

Mayor Bass announces executive order to delay Lineage rebuilding requests

Los Angeles Mayor Karen Bass has issued an executive order to delay all rebuilding requests from Lineage Logistics for its Boyle Heights warehouse, which was severely damaged by a fire. The order will remain in effect pending an investigation into the property and its …

(MLP) as a Liquidity Pulse for Institutional Tactics

This article analyzes Maui Land & Pineapple Company Inc. (NYSE: MLP) using AI models to provide institutional trading strategies. It highlights a strong sentiment in the near and mid-term, suggesting potential extension to the long term, and identifies an exceptional short setup with a …

SABESP (SBS) investors face conditional EMAE share merger pending EMAE vote

SABESP shareholders have approved the merger of all EMAE shares not already held by SABESP into SABESP, with EMAE shareholders set to receive SABESP common shares. However, the effectiveness of this merger is conditional upon approval by EMAE's own Extraordinary General Shareholders' Meeting, which …

Pineapple Resources Berhad Announces Resignation of Chow Foong Yew as Chairman of Nomination and Remuneration Committee, Effective July 31, 2026

Amneal Pharmaceuticals Inc (AMRX) (Q2 2026) Earnings Call Highlights: Record Revenue and Raised ...

AMRX Down Despite Q2 Earnings Beat, 2026 Revenue Outlook Raised

Amneal Pharmaceuticals AMRX reported second-quarter 2026 adjusted earnings of 30 cents per share, which beat the Zacks Consensus Estimate of 24 cents. Earnings increased 20% year over year, driven by strong performance across the company's three business segments. Total revenues of $796 million in …

Why a Boyle Heights man thinks a Lineage warehouse is making him sick

Boyle Heights residents living near a Lineage cold storage facility, which caught fire weeks ago, are reporting illnesses such as headaches, nausea, and severe respiratory issues, suspecting they are caused by the smoke and foul odors from decomposing food. One resident, Jesus Samaniego, now …

MXL Stock Set To Snap Four-Day Winning Streak Despite Q2 Beat — Wall Street Doubles Down On MaxLinear's AI Infrastructure Growth

MaxLinear (MXL) shares are set to end a four-day winning streak despite exceeding Q2 earnings expectations and providing strong guidance, fueled by growth in its optical infrastructure business. Wall Street analysts have reiterated "Buy" ratings and increased price targets, citing robust data center demand …

Amneal projects 2026 revenue of $3.1B-$3.2B while raising capex to about $150M

Earnings Call Insights: Amneal Pharmaceuticals (AMRX) Q2 2026 MANAGEMENT VIEW * "Amneal is in the midst of the most transformative period in our company's history," said (Co-Founder, Co-CEO, President & Director Chirag Patel), adding the company is "growing as one of the America's leading …

Earnings call transcript: Amneal tops Q2 2026 estimates, but shares slip

Amneal Pharmaceuticals reported stronger-than-expected Q2 2026 earnings and revenue, with adjusted EPS at $0.30 and revenue at $796.2 million, beating analyst estimates. Despite the strong performance and raised full-year guidance, the stock saw a slight premarket dip, potentially due to its proximity to its …

Compared to Estimates, Amneal (AMRX) Q2 Earnings: A Look at Key Metrics

For the quarter ended June 2026, Amneal Pharmaceuticals (AMRX) reported revenue of $796.2 million, up 9.9% over the same period last year. EPS came in at $0.30, compared to $0.25 in the year-ago quarter. The reported revenue represents a surprise of +3.7% over the …

Amneal Pharmaceuticals (AMRX) Q2 Earnings and Revenues Surpass Estimates

Amneal Pharmaceuticals (AMRX) came out with quarterly earnings of $0.3 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.25 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …

Amneal (NASDAQ:AMRX) Beats Expectations in Strong Q2 CY2026, Stock Jumps 15.9%

Amneal (NASDAQ:AMRX) Beats Expectations in Strong Q2 CY2026, Stock Jumps 15.9% Pharmaceutical company Amneal Pharmaceuticals (NASDAQ:AMRX) reported Q2 CY2026 results topping the market's revenue expectations , with sales up 9.9% year on year to $796.2 million. The company's full-year revenue guidance of $3.15 billion …

Amneal: Q2 Earnings Snapshot

Maui Land & Pineapple (NYSE:MLP) Stock Passes Above Two Hundred Day Moving Average - Here's What Happened

Shares of Maui Land & Pineapple (NYSE:MLP) surpassed their 200-day moving average, trading as high as $17.89, with a current price of $17.86. The company has faced recent downgrades from analysts, holding a consensus "Sell" rating. Financial performance shows a negative P/E ratio and …

Amneal Pharmaceuticals (AMRX) Wins FDA Nod For Iohexol, Is The Upside Already Priced In?

Amneal Pharmaceuticals (AMRX) recently received FDA approval for additional strengths and vial sizes of its iohexol injection, boosting its product portfolio and contributing to strong share price momentum. While analysts consider the stock about 5% overvalued with a fair value of $18.25, Simply Wall …

Pineapple Resources Berhad Appoints Kenny Chin Wui Chee as Independent and Non Executive Member of the Audit Committee, Effective 30 July 2026

Lineage Cell Therapeutics’ Aug. 6 call includes a business update

Lineage Cell Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026